NCT06466317 Is There Effect of Adding Honey Intake to Free Walking in Metabolic Syndrome Children
| NCT ID | NCT06466317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ahram Canadian University |
| Condition | Metabolic Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-06-06 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-06-06 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Metabolic Syndrome is common in Children and complementary therapies are important in its treatment such exercise and functional food intake including honey.
Eligibility Criteria
Inclusion Criteria: * 40 metabolic syndrome children Exclusion Criteria: * respiratory, cardiac , renal , liver problems
Contact & Investigator
hagar el-hadidy, lecturer
PRINCIPAL INVESTIGATOR
Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt
Frequently Asked Questions
Who can join the NCT06466317 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying Metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06466317 currently recruiting?
Yes, NCT06466317 is actively recruiting participants. Contact the research team at hagarhadidy2016@gmail.com for enrollment information.
Where is the NCT06466317 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06466317 clinical trial?
NCT06466317 is sponsored by Ahram Canadian University. The principal investigator is hagar el-hadidy, lecturer at Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt. The trial plans to enroll 40 participants.